JAZZ Venture Partners — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course.
BiotechDigital HealthMedical DevicesMental HealthBurlingame, US
Nolan Williams(Director)Christian Gormsen(Executive Officer, Director)inVikram Lamba(Executive Officer)in
BoardXingjuan Chao(Director)inHeath Lukatch(Director)
Board seatAndrew Firlik· per SEC Form D
Co-investorsDolby Family VenturesRed Tree Venture
Eternal is a personalized health platform that combines wearable data, lab results, and AI coaching to deliver customized podcasts, daily texts, and in-person care for fitness, health, and longevity.
HealthtechLongevityWellness & FitnessNew York, US
Co-investorsBling CapitalFlare Capital PartnersNext VenturesTerrainTreble CapitalCourtside Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






